Prostate
| TREATMENT REGIMENS | |||||
|---|---|---|---|---|---|
| Sensitive to castration | |||||
| Hormonotherapy | |||||
| Apalutamide | |||||
| Bicalutamide | |||||
| Chemotherapy | |||||
| Darolutamide + ADT+ docetaxel | |||||
| Docetaxel | |||||
| Castration-resistant - non metastatic | |||||
| Hormonotherapy | |||||
| Enzalutamide | |||||
| Apalutamide | |||||
| Castration-resistant - metastatic | |||||
| Hormonotherapy | |||||
| Abiraterone + prednisone | |||||
| Enzalutamide | |||||
| Chemotherapy | |||||
| Docetaxel + prednisone | |||||
| Cabazitaxel + prednisone | |||||
| Others | |||||
Groupe d'étude en oncologie du Québec